Inventor · disambiguated record
Anna I. Mandinova
Also filed as: MANDINOVA ANNA · MANDINOVA ANNA I
10 granted patents·14 pending applications·12 citations·filing 2004–2023
84Inventor score
Files withMASSACHUSETTS GEN HOSPITAL8HARVARD COLLEGE4GEN HOSPITAL CORP3FOLEY MICHAEL ANDREW2MAINE MEDICAL CT RES INST2
Top patents by PatentIndex Score
24 records- 0179US11701437B2Systemic delivery of polypeptidesHARVARD COLLEGE·Filed 2018·Granted Jul 18, 2023·1 cites·34 claims
- 0279US8349832B2Compounds and compositions for treating cancerCanthera Therapeutics·Filed 2010·Granted Jan 8, 2013·4 cites·12 claims
- 0375US10443038B2Agents and methods for treating and preventing seborrheic keratosisMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Oct 15, 2019·1 cites·7 claims
- 0475US8318737B2Compounds and compositions for treating cancerFOLEY MICHAEL ANDREW·Filed 2011·Granted Nov 27, 2012·2 cites·9 claims
- 0573US10822586B2Agents and methods for treating and preventing seborrheic keratosisMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Nov 3, 2020·0 cites·9 claims
- 0669US2024091384A1Systemic Delivery of PolypeptidesHARVARD COLLEGE·Filed 2023·Application pending·0 cites
- 0768US8232318B2Approaches to treat cancer using HB-EGF inhibitorsLEE SAM W·Filed 2010·Granted Jul 31, 2012·3 cites·16 claims
- 0866US10508309B2Methods for detecting and treating variants of seborrheic keratosesMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Dec 17, 2019·1 cites·4 claims
- 0960US9458462B2Agents and methods for treating and preventing seborrheic keratosisMASSACHUSETTS GEN HOSPITAL·Filed 2013·Granted Oct 4, 2016·0 cites·6 claims
- 1059US9658210B2Agents and methods for treating and preventing seborrheic keratosisMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted May 23, 2017·0 cites·9 claims
- 1156US2017211041A1Agents and methods for treating and preventing seborrheic keratosisMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 1254US9469606B2Wnt/b-catenin inhibitors and methods of useMASSACHUSETTS GEN HOSPITAL·Filed 2012·Granted Oct 18, 2016·0 cites·9 claims
- 1353US2011091387A1Methods and compositions for reducing skin damageGEN HOSPITAL CORP·Filed 2008·Application pending·0 cites
- 1453US2013203757A1Compounds And Compositions For Treating CancerCANTHERA THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 1552US2009312373A1Methods for the treatment of cancer using piperlongumine and piperlongumine analogsGEN HOSPITAL CORP·Filed 2009·Application pending·0 cites
- 1649US2013237539A1Compounds and Compositions for Treating CancerGEN HOSPITAL CORP·Filed 2013·Application pending·0 cites
- 1749US2009123565A9Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating theretoMAINE MEDICAL CT RES INST·Filed 2006·Application pending·0 cites
- 1849US2004229796A1Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating theretoMAINE MEDICAL CT RES INST·Filed 2004·Application pending·0 cites
- 1946US2014186277A1Methods and Compositions for Reducing Skin DamageSHISEIDO CO LTD·Filed 2013·Application pending·0 cites
- 2045US2020375868A1Systemic Delivery of PolypeptidesHARVARD COLLEGE·Filed 2018·Application pending·0 cites
- 2145US2022001027A1Genetically Engineered Skin Cells for the Systemic In Vivo Treatment of Deficient Enzymes, Factors or ProteinsHARVARD COLLEGE·Filed 2019·Application pending·0 cites
- 2239US2012157455A1Compounds And Compositions For Treating CancerFOLEY MICHAEL ANDREW·Filed 2011·Application pending·0 cites
- 2339US2019175646A1Methods and compositions relating to the treatment of benign skin tumorsTHE GENERAL HOSPITAL CORP D/B/A MASSACHUSETTS GENERAL HOSPITAL·Filed 2016·Application pending·0 cites
- 2435US2017184604A1Dd1alpha receptor and uses thereof in immune disordersMASSACHUSETTS GEN HOSPITAL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anna I. Mandinova files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →